1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Can‑
cer J Clin. 2020;70:7–30.
2. Tan CR, Yaffee PM, Jamil LH, et al. Pancreatic cancer cachexia:
a review of mechanisms and therapeutics. Front Physiol.
2014;5:88.
3. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised
European consensus on definition and diagnosis. Age Ageing.
2019;48:16–31.
4. Ozola Zalite I, Zykus R, Francisco Gonzalez M, et al. Influence of cachexia and sarcopenia on survival in pancreatic
ductal adenocarcinoma: a systematic review. Pancreatology.
2015;15:19–24.
S. Masuda et al.
5. Peng P, Hyder O, Firoozmand A, et al. Impact of sarcopenia on
outcomes following resection of pancreatic adenocarcinoma. J
Gastrointest Surg. 2012;16:1478–86.
6. Okumura S, Kaido T, Hamaguchi Y, et al. Impact of preoperative
quality as well as quantity of skeletal muscle on survival after
resection of pancreatic cancer. Surgery. 2015;157:1088–98.
7. Sugimoto M, Farnell MB, Nagorney DM, et al. Decreased skeletal muscle volume is a predictive factor for poorer survival
in patients undergoing surgical resection for pancreatic ductal
adenocarcinoma. J Gastrointest Surg. 2018;22:831–9.
8. Amini N, Spolverato G, Gupta R, et al. Impact total psoas volume
on short- and long-term outcomes in patients undergoing curative
resection for pancreatic adenocarcinoma: a new tool to assess
sarcopenia. J Gastrointest Surg. 2015;19:1593–602.
9. Nishida Y, Kato Y, Kudo M, et al. Preoperative sarcopenia
strongly influences the risk of postoperative pancreatic fistula
formation after pancreaticoduodenectomy. J Gastrointest Surg.
2016;20:1586–94.
10. Ratnayake CB, Loveday BP, Shrikhande SV, Windsor JA, Pandanaboyana S. Impact of preoperative sarcopenia on postoperative outcomes following pancreatic resection: a systematic
review and meta-analysis. Pancreatology. 2018;18:996–1004.
11. Pecorelli N, Carrara G, De Cobelli F, et al. Effect of sarcopenia
and visceral obesity on mortality and pancreatic fistula following
pancreatic cancer surgery. Br J Surg. 2016;103:434–42.
12. Pedersen BK, Febbraio MA. Muscle as an endocrine
organ: focus on muscle-derived interleukin-6. Physiol Rev.
2008;88:1379–406.
13. Lutz CT, Quinn LS. Sarcopenia, obesity, and natural killer cell
immune senescence in aging: altered cytokine levels as a common mechanism. Aging (Albany NY). 2012;4:535–46.
14. Shukla SK, Markov SD, Attri KS, et al. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic
cancer cachexia. Cancer Lett. 2020;484:29–39.
15. Brierley JD, Gospodarowicz MK, Wittekind C, editors. TNM
Classification of Malignant Tumours. Hoboken: Wiley; 2017.
16. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a
cohort of 6336 patients and results of a survey. Ann Surg.
2004;240:205–13.
17. Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update
of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery.
2017;161:584–91.
18. Nanno Y, Toyama H, Terai S, Mizumoto T, Tanaka M, Kido
M, Fukumoto T. Effect of oral branched-chain amino acid supplementation on postoperative blood lactate levels in patients
undergoing pancreatoduodenectomy. J Parenter Enter Nutr.
2018;42(5):960–4.
19. Mourtzakis M, Prado CMM, Lieffers JR, Reiman T, McCargar
LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed
tomography images acquired during routine care. Appl Physiol
Nutr Metab. 2008;33:997–1006.
20. Nishikawa H, Shiraki M, Hiramatsu A, Moriya K, Hino K, Nishiguchi S. Japan Society of Hepatology guidelines for sarcopenia
in liver disease (1st edition): Recommendation from the working
group for creation of sarcopenia assessment criteria. Hepatol
Res. 2016;46:951–63.
21. Tsujimae M, Masuda A, Ikegawa T, et al. Comprehensive analysis of molecular biologic characteristics of pancreatic ductal
adenocarcinoma concomitant with intraductal papillary mucinous neoplasm. Ann Surg Oncol. 2022;29:4924–34.
22. Qian ZR, Rubinson DA, Nowak JA, et al. Association of alterations in main driver genes with outcomes of patients with
Association of Sarcopenia with a … resected pancreatic ductal adenocarcinoma. JAMA Oncol.
2018;4:e173420.
23. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ:
25 years of image analysis. Nat Methods. 2012;9:671–5.
24. Schumacher TN, Thommen DS. Tertiary lymphoid structures in
cancer. Science. 2022;375(6576):eabf9419.
25. Rau BM, Moritz K, Schuschan S, Alsfasser G, Prall F, Klar E.
R1 resection in pancreatic cancer has significant impact on longterm outcome in standardized pathology modified for routine use.
Surgery. 2012;152:S103-111.
26. Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with
gemcitabine vs observation in patients undergoing curative-intent
resection of pancreatic cancer: a randomized controlled trial.
JAMA. 2007;297:267–77.
27. Uesaka K, Boku N, Fukutomi A, et al. Adjuvant chemotherapy
of S-1 versus gemcitabine for resected pancreatic cancer: a phase
3, open-label, randomised, non-inferiority trial (JASPAC 01).
Lancet. 2016;388:248–57.
28. Mintziras I, Miligkos M, Wachter S, Manoharan J, Maurer E,
Bartsch DK. Sarcopenia and sarcopenic obesity are significantly
associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis. Int J Surg.
2018;59:19–26.
5787
29. Ninomiya G, Fujii T, Yamada S, et al. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: a
retrospective cohort study. Int J Surg. 2017;39:45–51.
30. Joglekar S, Asghar A, Mott SL, et al. Sarcopenia is an independent predictor of complications following pancreatectomy
for adenocarcinoma. J Surg Oncol. 2015;111:771–5.
31. Chan MY, Chok KSH. Sarcopenia in pancreatic cancer - effects
on surgical outcomes and chemotherapy. World J Gastrointest
Oncol. 2019;11:527–37.
32. Nelke C, Dziewas R, Minnerup J, Meuth SG, Ruck T. Skeletal
muscle as potential central link between sarcopenia and immune
senescence. EBioMedicine. 2019;49:381–8.
33. Kitano Y, Yamashita YI, Saito Y, et al. Sarcopenia affects systemic and local immune system and impacts postoperative outcome in patients with extrahepatic cholangiocarcinoma. World
J Surg. 2019;43:2271–80.
Publisher’s Note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
...
論文の公開元へ
